CAS 1951 26 4 Amiodarone Drug 2 - Butyl - 3 - 3 , 5 - diiodo - 4 - Hydroxybenzoyl Benzofuran

CAS : 1951-26-4 Amiodarone Intermediate 2 - Butyl - 3 - ( 3 , 5 - diiodo - 4 - hydroxybenzoyl ) benzofuran

Chemical Name : 2 - Butyl - 3 - ( 3 , 5 - diiodo - 4 - hydroxybenzoyl ) benzofuran

CAS No . : 1951-26-4

Synonyms : ( 2 - Butyl - 3 - benzofuranyl ) ( 4 - hydroxy - 3 , 5 - diiodophenyl ) - methanone ; 2 - Butyl - 3 - benzofuranyl 4 - hydroxy - 3 , 5 - diiodophenyl ketone ; 2 - Butyl - 3 - ( 3 , 5 - diiodo - 4 - hydroxy benzoyl ) benzofuran

Molecular Formula : C19H16I2O3

Molecular Weight : 546.14

Usage : Amiodarone Intermediate

Description: Amiodarone is used to treat acute and also chronic arrhythmias, both in supraventricular and ventricular arrhythmias. A Belgium company called Labaz developed amiodarone in 1961. Amiodarone was commonly used in Europe to treat arrhythmias, but remained unapporoved by FDA in USA till December 1985. Amiodarone is one of the few drugs approved by FDA without rigorous randomized clinical trials.

2 - Butyl - 3 - ( 3 , 5 - diiodo - 4 - hydroxybenzoyl ) benzofuran CAS No . : 1951-26-4 is one of its intermediates. There are several synthesis routes to manufacture this intermediate but some routes are protected by the patents in some countries including Europe, USA and China. We strictly obey the laws and our commercial products are manufactured without infringing such patents. But anyway, the buyers should know the patent status by themselves. We promise to supply the real route of synthesis to the buyers. The buyers should take the risks of patent infringement by themselves.

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.